Dossiers d'AMM à évaluer par la commission spécialisée de Neurologie-Psychiatrie du 17/04/2018
| N° | NOM | DCI | DOSAGE | FORME | PRESENTATION | LABORATOIRE |
| 1 | RILUZOLE MYLAN | RILUZOLE | 50 mg | Cp pelliculé | B/56 | MYLAN SAS France |
| 2 | POLAR | OLANZAPINE | 15 mg | Cp pelliculé secable | B/30 | SAIPH |
| 3 | ZOPIX | ZOPICLONE | 3.75 mg | Cp pell | B/14 | SIMED |
| 4 | ZOPIX | ZOPICLONE | 7.5 mg | Cp pell sécable | B/14 | SIMED |
| 5 | ZOPICLAN | ZOPICLONE | 3.75 mg | Cp pell | B/5 | PHARMACARE |
| 6 | ZOPICLAN | ZOPICLONE | 7.5 mg | Cp pell sécable | B/5 | PHARMACARE |
| 7 | ZOPITAN | ZOLMITRIPTAN | 2.5 mg | Cp pell | B/12 | Taha Pharma |
| 8 | HALDOL | HALOPERIDOL | 1 mg | Cp | B/40 | JANSSEN |
| 9 | HALDOL | HALOPERIDOL | 5 mg/ml | sol injectable | B/5/1ml | JANSSEN |
| 10 | HALDOL DECANOAS | HALOPERIDOL | 50 mg | sol injectable | B/1/1ml | JANSSEN |
| 11 | HALDOL DECANOAS | HALOPERIDOL | 50 mg | sol injectable | B/5/1ml | JANSSEN |
| 12 | LEMTRADA | ALEMTUZUMAB | 12 mg | sol à diluer pour perf | B/1 Fl/1.2ml | GENZYME THERAPEUTIQUE LTD – UK |
